Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma

Journal of the American Academy of Dermatology

Volumn 61, Issue 2, 2009, Pages 247-251

  Ramachandran, Sudarshan ^a,b   Rajaratnam, Ratna ^c   Smith, Andrew G ^c   Lear, John T ^d   Strange, Richard C ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

Author keywords

basal cell carcinoma; squamous cell carcinoma; subsequent tumor

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CANCER RISK; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; ODDS RATIO; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 67650158429     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.03.015     Document Type: Article

References (18)

1. Ramachandran S., Lear J.T., Ramsay H., Smith A.G., Bowers B., Hutchinson P.E., et al. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype. Cancer Epidemiol Biomarkers Prev 8 (1999) 61-67
2. Ramachandran S., Fryer A.A., Smith A.G., Lear J.T., Bowers B., Griffiths C.E.M., et al. Basal cell carcinoma: tumor clustering is associated with increased accrual in high-risk subgroups. Cancer 89 (2000) 1012-1018
3. Marcil I., and Stern R.S. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer. Arch Dermatol 136 (2000) 1524-1530
4. Ramachandran S., Fryer A.A., Lovatt T., Smith A.G., Lear J.T., Jones P.W., et al. The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow up is associated with age at first presentation. Carcinogenesis 23 (2002) 2051-2054
5. Lear J.T., Tan B.B., Smith A.G., Bowers W., Jones P.W., Heagerty A.H., et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 90 (1997) 371-374
6. Fitzpatrick T.B. The validity and practicality of sun-reactive skin types 1 through 6. Arch Dermatol 124 (1988) 869-871
7. Karagas M.R., Greenberg R., Mott L.A., Baron J.A., and Ernster V.L. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer. Cancer Epidemiol Biomarkers Prev 7 (1998) 157-161
8. Frisch M., Hjalgrim H., Olsen J.H., and Melbye M. Risk for subsequent cancer after diagnosis of basal cell carcinoma. Ann Intern Med 125 (1996) 815-821
9. Karagas M.R., Stukel T., Greenberg E.R., Baron J.A., Mott L.A., Stern R.S., et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 267 (1992) 3305-3310
10. Kricker A., Armstrong B.K., English D.R., and Heenan P.J. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 60 (1995) 489-494
11. Rosso S., Zanetti R., Martinez C., Tormo M.J., Schraub S., Sancho-Garnier H., et al. The multicenter south European study 'Helios' II: different sun exposure patterns in the etiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 73 (1996) 1447-1454
12. Kricker A., Armstrong B.K., English D.R., and Heenan P.J. A dose-response curve for sun exposure and basal cell cancer. Int J Cancer 60 (1995) 482-488
13. Gallagher R.P., Hill G.B., Bajdik C.D., Fincham S., Coldman A.J., McLean D.I., et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer, I: basal cell carcinoma. Arch Dermatol 131 (1995) 157-163
14. Hunt M.J., Halliday G.M., Weedon D., Cooke B.E., and Barneston R.S. Regression in basal cell carcinoma: an immunohistochemical analysis. Br J Dermatol 130 (1994) 1-8
15. Urosevic M., and Dummer R. Immunotherapy for nonmelanoma skin cancer: does it have a future?. Cancer 94 (2002) 477-485
16. Haeffner A.C., Zepter K., Elmets C.A., and Wood G.S. Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma. Arch Dermatol 133 (1997) 585-590
17. Alomar A., Bichel J., and McRae S. Vehicle controlled, randomized, double blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratosis on the head. Br J Dermatol 157 (2007) 133-141
18. Barksdale S.K., O'Connor N., and Barnhill R. Prognostic factors for cutaneous squamous cell and basal cell carcinoma: determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Surg Oncol Clin N Am 6 (1997) 625-638